News
-
-
-
PRESS RELEASE
Sandoz confirms regulatory approval for new semaglutide treatment option in Brazil, paving way to expand patient access
Sandoz receives regulatory approval for Owozy®, a new semaglutide treatment for type-2 diabetes in Brazil, enhancing patient access and supporting local healthcare systems -
-
-
-
-
PRESS RELEASE
METLEN Signs Landmark Gallium Supply Agreement
METLEN announces a landmark gallium supply agreement with a leading US technology company, marking a major milestone for Europe's critical raw materials strategy. The agreement positions Greece and Europe in the forefront of a new strategic industrial value chain -
-